Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

Market Cap	11.60B
Revenue (ttm)	3.00B
Net Income (ttm)	532.43M
Shares Out	477.87M
EPS (ttm)	1.12
PE Ratio	21.62
Forward PE	18.26
Dividend	0.40 (1.64%)
Ex-Dividend Date	May 20, 2025

Volume	14,869,332
Average Volume	13,769,402
Open	23.89
Previous Close	24.43
Day's Range	23.89 - 24.95
52-Week Range	19.20 - 31.50
Beta	1.21
RSI	65.48
Earnings Date	Aug 26, 2025

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, infectious disease, cardiovascular, coagulation, diabetes and renal injury, fertility, infl...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 3,197
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300482

Financial Performance

In 2024, SHE:300482's revenue was 3.06 billion, an increase of 10.85% compared to the previous year's 2.76 billion. Earnings were 561.63 million, an increase of 15.18%.